(S)-1-piperideine-6-carboxylic acid

Metabolite details

Identifier

CSDPVAKVEWETFG-YFKPBYRVSA-N

InChI Key

CSDPVAKVEWETFG-YFKPBYRVSA-N

IUPAC name

(2S)-2,3,4,5-tetrahydropyridine-2-carboxylic acid

Preferred name

(S)-1-piperideine-6-carboxylic acid

INN name

—

Synonym

delta1-Piperideine-6-L-carboxylate

ChEBI

CHEBI:49014

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 10)
• Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• DNA-PKcs drives CKD progression by activating TAF7/RAPTOR/mTORC1 signaling-mediated metabolic reprogramming

Observed in differential profiles

• Sham_vs_UIR
• LLIR_vs_Control
• Control_vs_CSD
• DNA-PK_KO_UUO_vs_DNA-PK_KO_Control